Harvard to Use Health Care Device Developed by Vagustim

Vagustim, digital health technnology device maker, has succeeded in selling a product it developed in the field of bioelectronic medicine to Harvard Medical School. Vagustim is one of the companies at Istanbul Technical University (ITU) ARI Technopolis, an entrepreneurship and innovation base that has been boosting Turkey’s competitive power in the field of technology on a global scale. The digital health technology device developed by Vagustim in the field of bioelectronic medicine will be used by doctors and researchers in clinical studies at Harvard Medical School.

Developing the first and only mobile application-controlled and personalized vagus nerve stimulation device in the world with adjustable stimulation parameters, Vagustim’s product is a candidate for use in the treatment of dysfunction-related diseases caused by disruption of the balance of the autonomic nervous system that controls our vital organs and systems. The primary target indications of the device include chronic pain such as migraine and fibromyalgia, hyperinflammatory conditions caused by sports injury recovery and overreaction of the immune system, and autoimmune diseases.